Home Cart Sign in  
Chemical Structure| 107753-78-6 Chemical Structure| 107753-78-6

Structure of Zafirlukast
CAS No.: 107753-78-6

Chemical Structure| 107753-78-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Zafirlukast is the first-approved LTR antagonist with anti-asthmatic and potential capsular contracture-preventing activities.

Synonyms: ICI 204219

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Zafirlukast

CAS No. :107753-78-6
Formula : C31H33N3O6S
M.W : 575.68
SMILES Code : O=C(OC1CCCC1)NC2=CC3=C(N(C)C=C3CC4=CC=C(C(NS(=O)(C5=CC=CC=C5C)=O)=O)C=C4OC)C=C2
Synonyms :
ICI 204219
InChI Key :YEEZWCHGZNKEEK-UHFFFAOYSA-N
Pubchem ID :5717

Safety of Zafirlukast

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • LTR

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01125748 Allergic Asthma Phase 4 Completed - -
NCT01125748 - Completed - -
NCT01283061 Healthy PHASE1 COMPLETED 2025-01-08 BA Research India Ltd., Ahmeda... More >>bad, Bodakdev, 380 054, India Less <<
NCT02950480 Breast Cancer Phase 2 Recruiting January 2020 United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94143-1711 Contact: Pamela N. Munster, MD    877-827-3222    cancertrials@ucsf.edu Less <<
NCT04339140 Ovarian Cancer PHASE2 COMPLETED 2024-12-31 Beth Israel Deaconess Medical ... More >>Center, Boston, Massachusetts, 02215, United States Less <<
NCT06069063 Allergy to Cats PHASE2 NOT_YET_RECRUITING 2025-07-24 -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.74mL

0.35mL

0.17mL

8.69mL

1.74mL

0.87mL

17.37mL

3.47mL

1.74mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories